DEBORAH JONES-SHOOK: Open Payments
NPI 1962593228 · HUNT VALLEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$427 in 14 payments from 8 companies in 2025. Trend: 2023 $323 · 2024 $736 · 2025 $427
Food & beverage: $427
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $149 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $104 |
| Medtronic, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Orexo US, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
Products named: Ozempic, XIFAXAN, MOUNJARO, Rybelsus, Kerendia, Zubsolv, NURTEC ODT, CLOSUREFAST.
Industry payments across MD — which companies pay providers there.
